SpecialityChief Medical Officer and Head of Development at Denali Therapeutics

BiographyCarole Ho is the Chief Medical Officer of Denali Therapeutics. Carole’s curiosity of how the brain functions in health and disease guided her career from clinical neurologist to bench neuroscientist at Harvard and Stanford, after which she moved on to Genentech as an industry drug developer. She has a passion for innovative approaches to tailoring therapies for those that are most likely to respond. She has provided leadership for a landmark prevention trial in familial inherited Alzheimer's Disease in an extended Colombian family and has successfully translated genetic discoveries to therapies in the clinic at Genentech.